Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineAstraZeneca to take a dose of Circassia
FTSE 100 drugs giant AstraZeneca (AZN) is to become a 14.3% shareholder in small cap speciality pharma business Circassia (CIR). The latter is buying US commercial rights to two products from AstraZeneca in a cash and shares deal. AstraZeneca will displace Touchstone Innovations (IVO) as the biggest listed shareholder; Touchstone presently owns 9.3% of Circassia, according to Reuters. (DC)
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell Youinvest.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Big News
- 888 comes up trumps
- Argos saves the day for Sainsbury’s
- The fund which can help you beat inflation
- Setting the course for Brexit
- Has Royal Mail delivered for investors?
- Investor makes £2bn move on Anglo
- Watch NHS risk with Medica
- AstraZeneca to take a dose of Circassia
- Cheap mortgages could free up cash for investing
Editor's View
Great Ideas Update
Investment Trusts
Larger Companies
Main Feature
Smaller Companies
Story In Numbers
- UK Media Companies
- FTSE 100 Stocks - Best Performing
- 2.1%: House price growth in East Midlands in top form
- $23 billion: Behemoth created by Vodafone India merger
- Hansteen disposal worth more than its market cap
- 15%: Rights issue might not solve Tullow’s debt problem
- 22%: Recruiter enjoys strong growth in Asia
- 1.01%: BEST RATE FOR CASH ISA
